Macrogen Europe opens sequencing lab in Maastricht 

Macrogen Europe has opened a new sequencing facility in Maastricht. It is located close to the Netherlands’ southern border, which, combined with a fast in-house sample pickup service, means that Macrogen Europe can now offer Sanger sequencing results within 24 hours of sample pickup throughout Belgium and the Netherlands. 

The new lab, part of the Brightlands Maastricht Health Campus, is now processing commercial samples following a successful testing and validation process. It uses the same equipment, procedures and quality standards as Macrogen Europe’s main lab facility to ensure that data quality and consistency are unaffected – and that results between the facilities are fully comparable. 

John Lee, Head of Macrogen Europe’s Sanger sequencing division, said: “This expansion is great news for our clients, not just in the Benelux area, but across Europe and Africa. The increased capacity means that we can continue to deliver a fast, reliable service at a time of increased orders – and to many of our clients we can even offer a much faster service than before.” 

Dr Bongcho Kim, CEO of Macrogen Europe, said: “Opening this new facility in Maastricht is a key step to offering a more decentralized, local service with the fastest possible turnaround time.” 

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free